Early application of different dose of Calsurf for respiratory distress syndrome in term and late- preterm neonates: a randomised controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001696

Enrollment

Unknown

Registered

2011-11-07

Start date

2011-07-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory Distress Syndrome

Interventions

group 1:Calsurf 50mg/kg

group 2:Calsurf 70mg/kg

Eligibility

Sex/Gender

All

Age

No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. >= 33 weeks' gestation; 2. NRDS in the first week of life; 3. Diagnoses of NRDS: clinical manifestation: (1) RR>60/min; (2) Central cyanosis; (3) Flaring of alaenasi; (4) Three Depression Sign are positive; (5) Groan; 4. OI(oxygenation index)>=10; OI= FiO2(%)*MAP (cm H2O)/ PaO2 (mm Hg).

Exclusion criteria

Exclusion criteria: 1. Congenital heart disease; 2. Air Leak syndrome; 3. extrapulmonary acut respiratory distress syndrome.

Design outcomes

Primary

Measure	Time frame
blood gas;	—

Countries

China

Contacts

Public ContactHUI WU

wuhui97@126.com+86 15843079689

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026